Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series
Alzheimer disease (AD) is the most common cause of dementia worldwide. Its clinical manifestations include a progressive loss of memory and other cognitive domains, as well as brain atrophy. An elevated homocysteine level (>15 µmol/L), known as hyperhomocysteinemia, is also an attributing risk fa...
| Autors principals: | , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Korea Geriatrics Society
2024-03-01
|
| Col·lecció: | Annals of Geriatric Medicine and Research |
| Matèries: | |
| Accés en línia: | http://www.e-agmr.org/upload/pdf/agmr-23-0135.pdf |